CPT® Code 80100

Deleted

1. Indications

The qualitative drug screen using CPT® Code 80100 is indicated for the detection of multiple drug classes in various clinical scenarios. The following conditions may warrant the use of this procedure:

• Substance Abuse Evaluation This procedure is often performed to assess individuals for potential substance abuse issues, providing critical information for treatment and intervention.
• Pre-Employment Screening Employers may require drug screening as part of the hiring process to ensure a drug-free workplace.
• Monitoring Treatment Compliance Patients undergoing treatment for substance use disorders may be regularly screened to monitor compliance with prescribed therapies.
• Legal and Forensic Testing Drug screens may be utilized in legal contexts, such as probation monitoring or custody disputes, to provide evidence of drug use.

2. Procedure

The procedure for conducting a qualitative drug screen using the chromatographic method involves several key steps, which are detailed below:

• Specimen Collection A specimen, such as urine, blood serum, saliva, sweat, or hair, is collected from the patient. Proper collection techniques must be followed to ensure the integrity of the sample.
• Preparation of the Chromatography Plate A small amount of the collected specimen is applied to a chromatography plate that has been pre-coated with an organic binder. This preparation is crucial for the subsequent separation of drug components.
• Solvent Application The chromatography plate is positioned vertically, and the bottom edge is immersed in a solvent. The solvent travels up the plate, carrying the specimen with it and facilitating the separation of different components based on their molecular weight and affinity for the binder.
• Visualization of Results After the solvent has ascended the plate, an ultraviolet light or chemical spray is applied to visualize the separated components. This step allows for the identification of streaks or spots corresponding to specific drug classes.
• Comparison to Standards The visualized results are compared against established chromatogram standards to determine the presence of specific drugs or drug classes in the specimen.
• Reporting Each procedure performed is reported using CPT® Code 80100, ensuring accurate documentation for billing and compliance purposes.

3. Post-Procedure

After the qualitative drug screen is completed, the results are typically reviewed and interpreted by a qualified laboratory professional. If the test indicates the presence of drugs, further confirmatory testing may be required to validate the results. Patients may be advised on the next steps based on the findings, which could include counseling, treatment options, or legal implications depending on the context of the testing. It is essential to maintain proper documentation of the procedure and results for compliance and billing purposes.